Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Cash from Investing Activities (2021 - 2025)

Historic Cash from Investing Activities for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to $1000.0.

  • Biofrontera's Cash from Investing Activities changed N/A to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4000.0, marking a year-over-year decrease of 10063.19%. This contributed to the annual value of -$3000.0 for FY2024, which is 10048.47% down from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Cash from Investing Activities is $1000.0.
  • Biofrontera's 5-year Cash from Investing Activities high stood at $382000.0 for Q3 2023, and its period low was -$3.0 million during Q3 2022.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$2000.0 (2024), whereas its average is -$324928.6.
  • As far as peak fluctuations go, Biofrontera's Cash from Investing Activities tumbled by 30350000.0% in 2022, and later surged by 67419.35% in 2023.
  • Quarter analysis of 5 years shows Biofrontera's Cash from Investing Activities stood at -$9000.0 in 2021, then crashed by 23077.78% to -$2.1 million in 2022, then soared by 103.5% to $73000.0 in 2023, then plummeted by 101.37% to -$1000.0 in 2024, then soared by 200.0% to $1000.0 in 2025.
  • Its last three reported values are $1000.0 in Q3 2025, -$1000.0 for Q2 2025, and -$3000.0 during Q1 2025.